Resumen de acción AJANTPHARM
Ajanta Pharma Limited, una empresa de formulación de especialidades farmacéuticas, junto con sus filiales, desarrolla, fabrica y comercializa especialidades farmacéuticas en dosis acabadas.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Competidores de Ajanta Pharma Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2,409.65 |
| 52 Week High | ₹2,540.00 |
| 52 Week Low | ₹1,246.75 |
| Beta | 0.018 |
| 1 Month Change | 12.05% |
| 3 Month Change | 11.25% |
| 1 Year Change | 90.00% |
| 3 Year Change | 80.27% |
| 5 Year Change | 248.75% |
| Change since IPO | 15,285.11% |
Noticias y actualizaciones recientes
Ajanta Pharma Limited (NSE:AJANTPHARM) Analysts Are Pretty Bullish On The Stock After Recent Results
May 05
Ajanta Pharma Limited's (NSE:AJANTPHARM) Intrinsic Value Is Potentially 23% Below Its Share Price
Apr 05Recent updates
Ajanta Pharma Limited (NSE:AJANTPHARM) Analysts Are Pretty Bullish On The Stock After Recent Results
May 05Ajanta Pharma Limited's (NSE:AJANTPHARM) Intrinsic Value Is Potentially 23% Below Its Share Price
Apr 05We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease
Feb 23Ajanta Pharma Limited (NSE:AJANTPHARM) Investors Are Less Pessimistic Than Expected
Dec 23Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly
Aug 26These 4 Measures Indicate That Ajanta Pharma (NSE:AJANTPHARM) Is Using Debt Reasonably Well
Feb 07Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors
Oct 24Estimating The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Aug 25Is Now The Time To Put Ajanta Pharma (NSE:AJANTPHARM) On Your Watchlist?
Jul 19A Look At The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Apr 28Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly
Mar 14I Built A List Of Growing Companies And Ajanta Pharma (NSE:AJANTPHARM) Made The Cut
Feb 06Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Dec 13Ajanta Pharma (NSE:AJANTPHARM) Will Pay A Dividend Of ₹9.50
Oct 31Here's Why We Think Ajanta Pharma (NSE:AJANTPHARM) Is Well Worth Watching
Sep 22Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 27% Discount?
Sep 08Does Ajanta Pharma (NSE:AJANTPHARM) Have A Healthy Balance Sheet?
Aug 26Here's Why Shareholders Will Not Be Complaining About Ajanta Pharma Limited's (NSE:AJANTPHARM) CEO Pay Packet
Jul 07Should You Be Adding Ajanta Pharma (NSE:AJANTPHARM) To Your Watchlist Today?
Jun 14Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 30% Discount?
May 15Ajanta Pharma Limited (NSE:AJANTPHARM) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 10Ajanta Pharma Limited's (NSE:AJANTPHARM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
Mar 11Does Ajanta Pharma (NSE:AJANTPHARM) Deserve A Spot On Your Watchlist?
Feb 24The Ajanta Pharma (NSE:AJANTPHARM) Share Price Is Up 56% And Shareholders Are Holding On
Jan 30
What Can We Make Of Ajanta Pharma's (NSE:AJANTPHARM) CEO Compensation?
Jan 18Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Jan 06What Percentage Of Ajanta Pharma Limited (NSE:AJANTPHARM) Shares Do Insiders Own?
Dec 25You Have To Love Ajanta Pharma Limited's (NSE:AJANTPHARM) Dividend
Dec 13Is Ajanta Pharma Limited's (NSE:AJANTPHARM) Recent Stock Performance Influenced By Its Financials In Any Way?
Dec 01With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Is Interesting
Nov 19Rentabilidad de los accionistas
| AJANTPHARM | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | 7.9% | -0.8% | -1.5% |
| 1Y | 90.0% | 56.0% | 41.4% |
Rentabilidad vs. Industria: AJANTPHARM superó al sector Indian Pharmaceuticals , que obtuvo un rendimiento del 56.7% el año pasado.
Rentabilidad vs. Mercado: AJANTPHARM superó al mercado Indian, que obtuvo un rendimiento del 46.4% el año pasado.
Volatilidad de los precios
| AJANTPHARM volatility | |
|---|---|
| AJANTPHARM Average Weekly Movement | 4.1% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in IN Market | 9.8% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: AJANTPHARM no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de AJANTPHARM (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1973 | 7,713 | Yogesh Agrawal | www.ajantapharma.com |
Ajanta Pharma Limited, una empresa de formulación de especialidades farmacéuticas, junto con sus filiales, desarrolla, fabrica y comercializa especialidades farmacéuticas en dosis acabadas. La empresa comercializa y presta servicio a diversos segmentos terapéuticos, como antipalúdicos, cardiología, oftalmología, dermatología, tratamiento del dolor, gastroenterología, antihistamínicos, respiratorio y diabetes. También suministra comprimidos, cápsulas, polvos, líquidos, jaleas, pomadas, colirios estériles e ingredientes farmacéuticos activos.
Resumen de fundamentos de Ajanta Pharma Limited
| Estadísticas fundamentales de AJANTPHARM | |
|---|---|
| Capitalización bursátil | ₹300.93b |
| Beneficios(TTM) | ₹8.16b |
| Ingresos (TTM) | ₹42.93b |
36.9x
Ratio precio-beneficio (PE)7.0x
Ratio precio-ventas (PS)¿Está AJANTPHARM sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de AJANTPHARM | |
|---|---|
| Ingresos | ₹42.93b |
| Coste de los ingresos | ₹10.67b |
| Beneficio bruto | ₹32.27b |
| Otros gastos | ₹24.11b |
| Beneficios | ₹8.16b |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 65.35 |
| Margen bruto | 75.16% |
| Margen de beneficio neto | 19.01% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado AJANTPHARM a largo plazo?
Ver rendimiento histórico y comparativa